These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15221098)

  • 1. [Databases as a source for monitoring systems of drug safety].
    Pigeot I; Ahrens W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):513-7. PubMed ID: 15221098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring adverse drug reactions across a nationwide health care system using information technology.
    Emmendorfer T; Glassman PA; Moore V; Leadholm TC; Good CB; Cunningham F
    Am J Health Syst Pharm; 2012 Feb; 69(4):321-8. PubMed ID: 22302257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
    Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug utilization studies within the VIDEOFAR project.
    Maggini M; Menniti Ippolito F; Spila Alegiani S; Traversa G; Fortini M
    Ann Ist Super Sanita; 1991; 27(2):201-6. PubMed ID: 1755571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Computerize all patient records by 2001'.
    Gardner E
    Mod Healthc; 1991 May; 21(19):4. PubMed ID: 10110474
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of routine data from statutory health insurances for federal health monitoring purposes].
    Ohlmeier C; Frick J; Prütz F; Lampert T; Ziese T; Mikolajczyk R; Garbe E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Apr; 57(4):464-72. PubMed ID: 24658676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The great state data debate.
    Palmer K
    Minn Med; 2003 Oct; 86(10):22-6. PubMed ID: 14621940
    [No Abstract]   [Full Text] [Related]  

  • 8. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefits of large healthcare databases for drug risk research].
    Garbe E; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
    Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Therapeutic Drug Committee of German Physicians. 50 years in the service of drug safety in Germany].
    Müller-Oerlinghausen B; Tiaden JD
    Internist (Berl); 2002 Apr; 43(4):482, 485-92. PubMed ID: 12053404
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [European drug agency and drug management].
    Barfuss W
    Leber Magen Darm; 1996 Jul; 26(4):191-2. PubMed ID: 8965600
    [No Abstract]   [Full Text] [Related]  

  • 16. [The safety and registration of pharmaceuticals from the point of view of the medical practitioner].
    Kaiser RH
    Radiologe; 2002 Dec; 42(12):1016-24; quiz 1024-5. PubMed ID: 12602329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Public health research with statutory health insurance drug data].
    Janhsen K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):521-5. PubMed ID: 15221100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacoepidemiological research with large health databases].
    Andersohn F; Garbe E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1135-44. PubMed ID: 18985407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug safety and post-marketing control. Developments since the reform of the 1978 drug regulation].
    Wille H; Schönhöfer PS
    Internist (Berl); 2002 Apr; 43(4):469-70, 473-81. PubMed ID: 12053403
    [No Abstract]   [Full Text] [Related]  

  • 20. [Definitions related to pharmacovigilance and drug safety].
    Möller H; Aly AF
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):709-11. PubMed ID: 23217722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.